Company news
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Kelun-Biotech Announces Approximately US$250 Million Placement
June 5, 2025
Six Abstracts of Kelun-Biotech's Clinical Studies Published at the 2025 ASCO Annual Meeting
May 23, 2025
Fourth NDA for Kelun-Biotech's TROP2 ADC sacituzumab tirumotecan (sac-TMT) Accepted by the Center for Drug Evaluation
May 21, 2025
Kelun-Biotech to Present Results of Six Clinical Studies at 2025 ASCO Annual Meeting
April 24, 2025